5-Fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer MDA-MB-453 cells.

Abstract:

:We investigated the effects of combined treatment with 5-fluorouracil and apigenin on proliferation and apoptosis, as well as the underlying mechanism, in human breast cancer MDA-MB-453 cells. The MDA-MB-453 cells, which have been shown to overexpress ErbB2, were resistant to 5-fluorouracil; 5-fluorouracil exhibited a small dose-dependent anti-proliferative effect, with an IC50 of 90 microM. Interestingly, combined treatment with apigenin significantly decreased the resistance. Cellular proliferation was significantly inhibited in cells exposed to 5-fluorouracil at its IC50 and apigenin (5, 10, 50 and 100 microM), compared with proliferation in cells exposed to 5-fluorouracil alone. This inhibition in turn led to apoptosis, as evidenced by an increased number of apoptotic cells and the activation of caspase-3. To investigate the mechanism by which the combination of 5-fluorouracil and apigenin induces apoptosis, ErbB2 expression was analyzed. The level of ErbB2 was unchanged by 5-fluorouracil alone but was drastically reduced in cells treated with 5-fluorouracil plus apigenin. Moreover, compared with 5-fluorouracil alone, 5-fluorouracil in combination with apigenin at concentrations >10 microM exerted a pro-apoptotic effect via the inhibition of Akt expression. Taken together, our results suggest that 5-fluorouracil acts synergistically with apigenin inhibiting cell growth and inducing apoptosis via the down-regulation of ErbB2 expression and Akt signaling.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Choi EJ,Kim GH

doi

10.3892/or_00000598

subject

Has Abstract

pub_date

2009-12-01 00:00:00

pages

1533-7

issue

6

eissn

1021-335X

issn

1791-2431

journal_volume

22

pub_type

杂志文章
  • Downregulation of miR‑200c‑3p contributes to the resistance of breast cancer cells to paclitaxel by targeting SOX2.

    abstract::Acquisition of resistance to paclitaxel is a major obstacle to successful treatment of breast cancer patients, but the molecular mechanisms underlying the development of drug resistance remain largely unclear. The aim of the present study was to investigate the role and mechanism of action of miR‑200c‑3p in the resist...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6735

    authors: Chen J,Tian W,He H,Chen F,Huang J,Wang X,Chen Z

    更新日期:2018-12-01 00:00:00

  • GnRH agonists and antagonists decrease the metastatic progression of human prostate cancer cell lines by inhibiting the plasminogen activator system.

    abstract::Prostate cancer (PCa) growth initially depends on circulating androgens. Gonadotropin-releasing hormone (GnRH) agonists are currently used for the treatment of PCa. However, after an initial responsiveness to hormonal deprivation, PCa progresses and metastasizes. Recently, also GnRH antagonists have been used for clin...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.15.2.393

    authors: Dondi D,Festuccia C,Piccolella M,Bologna M,Motta M

    更新日期:2006-02-01 00:00:00

  • Reduced expression and loss of heterozygosity of the SDHD gene in colorectal and gastric cancer.

    abstract::Mitochondrial DNA (mtDNA) mutations occur in a variety of human cancers, suggesting a possible role for mitochondrial respiratory functions in tumorigenesis. Recent studies have demonstrated that SDHD, a nuclear gene encoding one of the mitochondrial complex II subunits, acts as a tumor-suppressor for hereditary parag...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Habano W,Sugai T,Nakamura S,Uesugi N,Higuchi T,Terashima M,Horiuchi S

    更新日期:2003-09-01 00:00:00

  • Expression of DNA double-strand break repair proteins predicts the response and prognosis of colorectal cancer patients undergoing oxaliplatin-based chemotherapy.

    abstract::DNA intrastrand cross-linking agents such as oxaliplatin induce DNA double-strand breaks (DSBs) during DNA repair and replication. In the present study, we hypothesized that DNA intrastrand cross-linking agents may significantly benefit colorectal cancer patients with deficiencies in DSB repair. Seventy-eight patients...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4488

    authors: Ihara K,Yamaguchi S,Ueno N,Tani Y,Shida Y,Ogata H,Domeki Y,Okamoto K,Nakajima M,Sasaki K,Tsuchioka T,Mitomi H,Kato H

    更新日期:2016-03-01 00:00:00

  • Establishment of a human primary pancreatic cancer mouse model to examine and investigate gemcitabine resistance.

    abstract::Pancreatic cancer is one of the most fatal types of cancer and is associated with a dismal prognosis. Gemcitabine-based chemotherapy is clinically used for the treatment of advanced pancreatic cancer. However, many forms of pancreatic cancer have acquired resistance to gemcitabine. In order to prevent patients from su...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.6026

    authors: Zhang YJ,Wen CL,Qin YX,Tang XM,Shi MM,Shen BY,Fang Y

    更新日期:2017-12-01 00:00:00

  • Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR/Akt signaling and predicts a good prognosis in non‑small cell lung cancer.

    abstract::Gasdermin D (GSDMD) is a newly discovered pyroptosis executive protein, which can be cleaved by inflammatory caspases and is essential for secretion of IL‑1β, making it a critical mediator of inflammation. However, the precise role of GSDMD in carcinogenesis remains nearly unknown. Considering the vital role of inflam...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6634

    authors: Gao J,Qiu X,Xi G,Liu H,Zhang F,Lv T,Song Y

    更新日期:2018-10-01 00:00:00

  • Genome-wide cDNA microarray screening of genes related to survival in patients after curative resection of non-small cell lung cancer.

    abstract::We conducted a study to determine whether the expression levels of genes in tumors were correlated with the survival of patients after complete resection of non-small cell lung cancer (NSCLC). The expression levels of 1176 genes in resected tumor specimens from 28 patients were analyzed using the Atlastrade mark Human...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Oshita F,Sekiyama A,Ito H,Kameda Y,Miyagi Y

    更新日期:2006-10-01 00:00:00

  • [Retracted] Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway.

    abstract::Following the publication of this paper, it was drawn to the authors' attention by an interested reader that certain of the tumours featured in Fig. 6A of the above paper were strikingly similar to those featured in Fig. 8A of an article appearing in International Journal of Oncology (Fan F-Y, Deng R, Yi H, Sun H-P, Z...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7828

    authors: Zhang L,Liang X,Li Y

    更新日期:2021-01-01 00:00:00

  • Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.

    abstract::The ING1 gene is involved in the regulation of the cell cycle, senescence, and apoptosis and is a novel candidate tumor suppressor gene. ING2, another gene in the ING family, was identified and cloned. The functions of ING1 and ING2 largely depend on the activity of p53. To determine whether an alteration in these gen...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Okano T,Gemma A,Hosoya Y,Hosomi Y,Nara M,Kokubo Y,Yoshimura A,Shibuya M,Nagashima M,Harris CC,Kudoh S

    更新日期:2006-03-01 00:00:00

  • Esculetin inhibits cell proliferation through the Ras/ERK1/2 pathway in human colon cancer cells.

    abstract::Esculetin, a phenolic compound, has been shown to inhibit the growth of colon tumors in animal studies. However, the roles of signaling pathways and cell cycle regulation in the esculetin-induced inhibition of cancer cell growth, remain to be elucidated. The present study suggests a novel mechanism for the Ras/ERK1/2 ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Park SS,Park SK,Lim JH,Choi YH,Kim WJ,Moon SK

    更新日期:2011-01-01 00:00:00

  • Ligularia fischeri inhibits endothelial cell proliferation, invasion and tube formation through the inactivation of mitogenic signaling pathways and regulation of vascular endothelial cadherin distribution and matrix metalloproteinase expression.

    abstract::Ligularia fischeri (LF) has been used as an edible herb and traditional medicine for the treatment of inflammatory and infectious diseases. In the present study, we report the effects and molecular mechanism of the ethanolic extract of LF on cell proliferation, invasion and tube formation in human umbilical vein endot...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4000

    authors: Kim JH,Kim HJ,Kim JK,Ahn EK,Ko HJ,Cho YR,Lee SJ,Bae GU,Kim YK,Park JW,Oh JS,Seo DW

    更新日期:2015-07-01 00:00:00

  • Novel FGFR inhibitor ponatinib suppresses the growth of non-small cell lung cancer cells overexpressing FGFR1.

    abstract::Lung cancer is still the leading cause of cancer-related deaths worldwide. Identifying new oncogenic drivers and developing efficient inhibitors through molecular targeting approaches are crucial for improving therapies. The aim of this study was to investigate whether targeting fibroblast growth factor receptor 1 (FG...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2386

    authors: Ren M,Hong M,Liu G,Wang H,Patel V,Biddinger P,Silva J,Cowell J,Hao Z

    更新日期:2013-06-01 00:00:00

  • Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition.

    abstract::A small subset of cells within a malignant neoplasm, named cancer stem cells (CSCs) or tumour initiating cells, are thought to be capable of initiating the neoplasm itself, and of driving its growth and recurrence after treatment. It is unclear whether CSCs can be identified and experimentally induced within oral squa...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2011.1299

    authors: Qiao B,Johnson NW,Chen X,Li R,Tao Q,Gao J

    更新日期:2011-08-01 00:00:00

  • Epigenetic modulation of AR gene expression in prostate cancer DU145 cells with the combination of sodium butyrate and 5'-Aza-2'-deoxycytidine.

    abstract::The androgen receptor (AR) plays an essential role in the development and progression of prostate cancer. Castration-resistant prostate cancer (CRPC) is a consequence of androgen deprivation therapy. Unchecked CRPC followed by metastasis is lethal. Some CRPCs show decreased AR gene expression due to epigenetic mechani...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5000

    authors: Fialova B,Luzna P,Gursky J,Langova K,Kolar Z,Trtkova KS

    更新日期:2016-10-01 00:00:00

  • Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogue.

    abstract::Vitamin K2 (VK2) has been shown to have a potent anti-tumor effect against several cancer types including hepatocellular carcinoma (HCC), but the mechanisms remain to be elucidated. Matrix metalloproteinase (MMP) plays an important role in the invasion and metastasis of cancer cells, but it is not known whether VK2 re...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000478

    authors: Ide Y,Zhang H,Hamajima H,Kawaguchi Y,Eguchi Y,Mizuta T,Yamamoto K,Fujimoto K,Ozaki I

    更新日期:2009-09-01 00:00:00

  • Prognostic implications of node metastatic features in OSCC: a retrospective study on 121 neck dissections.

    abstract::Lymph node metastases are responsible for shorter survival in oral squamous cell carcinoma (OSCC). The aim of the present study was to assess the node metastasis frequency and survival according to the node metastasis features in 121 neck dissections (NDs) performed for OSCC, identifying evidence-based correlations an...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2779

    authors: Contaldo M,Di Napoli A,Pannone G,Franco R,Ionna F,Feola A,De Rosa A,Santoro A,Sbordone C,Longo F,Pasquali D,Loreto C,Ricciardiello F,Esposito G,D'Angelo L,Itro A,Bufo P,Tombolini V,Serpico R,Di Domenico M

    更新日期:2013-12-01 00:00:00

  • Expression and cisplatin sensitivity of copper-transporting P-type adenosine triphosphatase (ATP7B) in human solid carcinoma cell lines.

    abstract::One of the most important clinical problems in the treatment of human solid carcinoma is the intrinsic/acquired resistance. Cisplatin is a platinum compound that is one of the most effective agents in clinic. Copper-transporting P-type adenosine triphosphate (ATP7B) has been reported to be associated with cisplatin re...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.6.1285

    authors: Nakayama K,Miyazaki K,Kanzaki A,Fukumoto M,Takebayashi Y

    更新日期:2001-11-01 00:00:00

  • Tanshinone IIA can inhibit MiaPaCa‑2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways.

    abstract::Tanshinone IIA (Tan‑IIA; C19H18O3) is derived from Danshen (the roots of Salvia miltiorrhiza), and has been reported to possess anti‑inflammatory and antioxidant activities. Tan‑IIA can inhibit BxPC‑3 human pancreatic cancer cells in vitro through inducing endoplasmic reticulum stress and apoptosis via mitochondrial p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6670

    authors: Su CC

    更新日期:2018-11-01 00:00:00

  • Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells.

    abstract::Deregulation of c-Jun NH2-terminal kinase (JNK) signaling is now increasingly reported in a variety of human malignancies. Non-small cell lung cancer (NSCLC) is among such human malignancies with aberrant JNK activation; yet the exact role(s) of JNK deregulation in NSCLC biology, in particular in vivo, remains unclear...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2655

    authors: Okada M,Shibuya K,Sato A,Seino S,Watanabe E,Suzuki S,Seino M,Kitanaka C

    更新日期:2013-10-01 00:00:00

  • Effects of ephrinB2 gene siRNA on the biological behavior of human colorectal cancer cells.

    abstract::Colorectal cancer (CRC) is a common gastrointestinal malignancy worldwide and is a lethal and aggressive malignancy with a dismal prognosis. EphrinB2 is a membrane-bound ligand and has an intracellular domain that also possesses an intrinsic signaling capacity called 'reverse signaling'. In the present study, CRC cell...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3633

    authors: Li P,Chen W,Wang Y,Fu X,Wen K,Qian J,Huang C,Fu Z

    更新日期:2015-02-01 00:00:00

  • Genetic progression and divergence in superficial esophageal squamous cell carcinoma by loss of heterozygosity analysis.

    abstract::Esophageal squamous cell carcinoma (SCC) is one of the most common fatal carcinomas worldwide and has some of the most malignant characteristics among gastrointestinal tumors. Although a high frequency of loss of heterozygosity (LOH) for various genes has been observed in esophageal SCCs, these findings do not provide...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Shima H,Hiyama T,Tanaka S,Yoshihara M,Arihiro K,Chayama K

    更新日期:2006-10-01 00:00:00

  • Downregulation of miR-95 in gastric cancer promotes EMT via regulation of Slug, thereby promoting migration and invasion.

    abstract::miR-95 has been revealed to be aberrantly expressed in multiple types of cancer and to regulate tumor development. Moreover, miR-95 has been revealed to be downregulated in gastric cancer. However, the detailed function of miR-95 in gastric cancer has remained largely unknown. In the present study, we found that miR-9...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6911

    authors: Zhang W,Sun J,Chen J,Xu C,Zhang L

    更新日期:2019-02-01 00:00:00

  • A single nucleotide polymorphism in fibronectin 1 determines tumor shape in colorectal cancer.

    abstract::Depressed and flat surface lesions are not easy to identify with routine colonoscopies during screening for colorectal cancer (CRC). Identifying clinically relevant genes that influence tumor shape could be useful when screening for the presence of depressed lesions. Total RNA was extracted from tumor cells collected ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3251

    authors: Kida H,Takano Y,Yamamoto K,Mori M,Yanaga K,Tanaka J,Kudo SE,Mimori K

    更新日期:2014-08-01 00:00:00

  • Changes in bone resorption and vascular endothelial growth factor after a single zoledronic acid infusion in cancer patients with bone metastases from solid tumours.

    abstract::Zoledronic acid (Zometa, ZOL) is increasingly used to treat tumour-induced bone disease, and is also reported to have antiangiogenic properties in vivo. In this study, we have investigated the correlations between changes in the proangiogenic cytokine, vascular endothelial growth factor (VEGF), and markers of bone res...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Santini D,Vincenzi B,Hannon RA,Brown JE,Dicuonzo G,Angeletti S,La Cesa A,Coleman RE,Tonini G,Budillon A,Caraglia M,Holen I

    更新日期:2006-05-01 00:00:00

  • Antitumor effect of gefitinib on head and neck squamous cell carcinoma enhanced by trastuzumab.

    abstract::The overexpression of EGFR and/or HER-2 is associated with tumor cell resistance to chemotherapy, radiotherapy, disease progression and poor prognosis in patients with a variety of malignant tumors. Treatment combining the EGFR-targeting drug, gefitinib (ZD1839, Iressa) with the HER-2-targeting drug, trastuzumab (Herc...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kondo N,Ishiguro Y,Kimura M,Sano D,Fujita K,Sakakibara A,Taguchi T,Toth G,Matsuda H,Tsukuda M

    更新日期:2008-08-01 00:00:00

  • Effect of a specific supplement enriched with n-3 polyunsaturated fatty acids on markers of inflammation, oxidative stress and metabolic status of ear, nose and throat cancer patients.

    abstract::Malnutrition affects 40-50% of patients with ear, nose and throat (ENT) cancer. The aim of this study was to assess changes induced by a specific nutritional supplement enriched with n-3 polyunsaturated fatty acids, fiber and greater amounts of proteins and electrolytes, as compared with a standard nutritional supplem...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2806

    authors: Roca-Rodríguez MM,García-Almeida JM,Lupiañez-Pérez Y,Rico JM,Toledo M,Alcaide-Torres J,Cardona F,Medina JA,Tinahones FJ

    更新日期:2014-01-01 00:00:00

  • Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression.

    abstract::We previously found that oleanolic acid (OA), a naturally pentacyclic triterpenoid, enhances the radiosensitizing effect on tumor cells. However, it is unclear whether or not OA enhances the radiosensitivity of hypoxic cells. Therefore, the aim of the present study was to further observe the influence of OA on hypoxic...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2014.3064

    authors: Qi R,Jin W,Wang J,Yi Q,Yu M,Xu S,Jin W

    更新日期:2014-05-01 00:00:00

  • Macrophage‑derived exosomes attenuate the susceptibility of oral squamous cell carcinoma cells to chemotherapeutic drugs through the AKT/GSK‑3β pathway.

    abstract::Although chemotherapy is initially effective in debulking tumor mass in a number of different types of malignancy, tumor cells gradually acquire chemoresistance and frequently progress to advanced clinical stage. Accumulating evidence has indicated that the tumor sensitivity to several chemotherapeutic drugs is regula...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7748

    authors: Tomita R,Sasabe E,Tomomura A,Yamamoto T

    更新日期:2020-11-01 00:00:00

  • Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.

    abstract::Aberrant expression of microRNAs has been identified as regulators of biological processes of hepatocellular carcinoma (HCC) by negatively regulating protein-coding mRNAs. Several studies have demonstrated that miR-638 expression was dysregulated in various human cancers. However, the clinical significance and underly...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.5273

    authors: Zhang Y,Zhang D,Jiang J,Dong L

    更新日期:2017-01-01 00:00:00

  • Subdivision of molecularly-classified groups by new gene signatures in breast cancer patients.

    abstract::Gene expression patterns as well as gene interactions are under investigation for their involvement in tumour heterogeneity. The molecular classification of breast cancer based on hormone receptor expression, grade and HER2 receptor levels, is indicative but not adequate enough to c...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.2018

    authors: Armakolas A,Stathopoulos GP,Nezos A,Theos A,Stathaki M,Koutsilieris M

    更新日期:2012-12-01 00:00:00